ULTRAGENYX PHARMACEUTICAL IN (RARE)
US90400D1081 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to RARE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 91.19. This target is 113.31% above the current price.
RARE was analyzed by 27 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about RARE.
In the previous month the buy percentage consensus was at a similar level.
RARE was analyzed by 27 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-03 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-05-03 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-04-24 | TD Cowen | Maintains | Buy -> Buy |
| 2024-04-22 | RBC Capital | Initiate | Outperform |
| 2024-04-17 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-04-16 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-04-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-03-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-27 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-02-27 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-21 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-02-16 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-02-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-01-30 | Baird | Maintains | Outperform -> Outperform |
| 2024-01-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-12-08 | Wells Fargo | Initiate | Overweight |
| 2023-11-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-25 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-09-25 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-04 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-07 | Citigroup | Maintains | Buy -> Buy |
| 2023-06-06 | Wedbush | Maintains | Neutral -> Neutral |
| 2023-06-06 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2023-05-08 | Wedbush | Maintains | Neutral |
| 2023-05-05 | Credit Suisse | Reiterate | Outperform |
| 2023-04-26 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-02-17 | Baird | Maintains | Outperform |
| 2023-02-17 | Credit Suisse | Reiterate | Outperform |